News

We could know if a vaccine works this month

Welcome to Business Insider ‘ s daily healthcare newsletter , your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hello, …And suddenly it’s October! If anyone has good inspiration for a festive, spooky Twitter name, please let me know. […]
We could know if a vaccine works this month
News

Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient

Gilead Sciences could be justified in charging up to $US4,500 per coronavirus patient for its drug, a nonprofit pricing watchdog said in a recent report. The California biotech is the maker of remdesivir, an experimental antiviral treatment that helped hospitalized COVID-19 patients recover 31% faster, shaving four days off hospital […]
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
News

‘Like we were being forced to gamble with our son’s life’: Health insurers won’t pay for a $2.1 million drug for kids, and parents say they’re running out of time

A new type of therapy that treats a devastating inherited disease at the genetic level was recently approved in the US. Its $US2.1 million price tag makes the drug, Zolgensma, the most expensive in the world. Four parents of children born with the disease, called spinal muscular atrophy, told Business […]
‘Like we were being forced to gamble with our son’s life’: Health insurers won’t pay for a $2.1 million drug for kids, and parents say they’re running out of time
News

Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinical trial startups

Hello, Well, it’s official: Bristol-Myers Squibb and Celgene are likely going to form the megamerger of their dreams, after shareholders approved the $US74 billion union. Before heading into the weekend on that note, I wanted to leave you with a recap of all the news that kept Business Insider’s healthcare […]
Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinical trial startups
News

A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political crosshairs

On Monday, diabetes drugmaker Eli Lilly said it plans to make an “authorised generic” version of its life-saving diabetes medication Humalog and sell it for half the price of the branded version. Humalog is a type of short-acting insulin, which helps people with diabetes process the sugar in their blood. […]
A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political crosshairs
News

The Trump administration just took its biggest step yet to bring down the cost of prescription drugs — and it’s dividing the healthcare industry

The Trump administration just proposed a new rule that could bring down the cost of prescription drugs for patients. The Department of Health and Human Services wants to ban some payments, called rebates, between drugmakers and middlemen. Rebates are negotiated between middlemen called pharmacy benefit managers and drugmakers, and are […]
The Trump administration just took its biggest step yet to bring down the cost of prescription drugs — and it’s dividing the healthcare industry